Skip to main content
Clinical Trials/NCT02808221
NCT02808221
Unknown
Not Applicable

Readmission in the Case of Patients With Heart Failure

University Hospital, Strasbourg, France1 site in 1 country100 target enrollmentApril 2016
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
University Hospital, Strasbourg, France
Enrollment
100
Locations
1
Primary Endpoint
The cost of re-hospitalization in the case of patients with heart failure reach
Last Updated
8 years ago

Overview

Brief Summary

Heart failure (HF) is a serious chronic disease with frequent readmissions, some of which can be prevented by early action. The management of HF is complex: long, often difficult and costly. In France, nearly one million people suffer from HF and 120,000 new cases are diagnosed every year. With the aging population, this number will continue to evolve and become a real public health problem. Within 10 to 20 years ahead, WHO projects that heart failure in either the 3 most common diseases in industrialized countries.

Investigators goals are to make an inventory of PRADO-IC project in terms of its effectiveness on readmission of patients with heart failure.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
September 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient aged 18 or over
  • Patient readmitted for heart failure

Exclusion Criteria

  • Population whose age is less than 18 years

Outcomes

Primary Outcomes

The cost of re-hospitalization in the case of patients with heart failure reach

Time Frame: during 2015

Study Sites (1)

Loading locations...

Similar Trials